| Application: | Home |
|---|---|
| Disposable: | Disposable |
| Gender: | Unisex |
| Side Effect: | No |
| Usage: | For External Use |
| Pharmaceutical Technology: | Natural Product Extraction |
| Samples: |
|---|
Suppliers with verified business licenses
Audited Supplier What is semaglutide?
Semaglutide acts similar to a human glucagon peptide-1 (GLP-1) that works similar to a hormone produced in our body called incretin. Incretin stimulates insulin secretion and sugar metabolism in response to increased glucose levels which usually occurs after meals. Patients with type 2 diabetes are usually at a total loss with incretin production.
In addition to lowering blood sugar levels, Ozempic lowers blood pressure, suppresses appetite and assists in chronic weight management.
It is also used for patients with heart disease and reduces the risk of death from stroke or heart attack.
Semaglutide should be used in combination with a proper diet and regular exercise.
It is not intended to be used as a substitute for insulin treatment.
Ozempic is available as a prefilled disposable single-use injectable pen available in either 0.25mg and 1mg increments which is both safe and easy to administer even for those starting out.
A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received metformin and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease.
Based on the natural human GLP-1 molecule, the eighth (alanine → alpha-aminobutyric acid) and the 34th amino acid (lysine → arginine) were substituted, while lysine at the 26th was linked to the C18 adipose acid side chain by spacer group. After the modification of human GLP-1 molecule, Smeiglutide can resist the degradation of dipeptidyl peptidase 4 (DPP-4), bind closely to albumin, significantly prolong the half-life in vivo, achieve once a week administration, and retain up to 94% of GLP-1 amino acid sequence homology, with good safety.
In December 2017, the US Food and Drug Administration (FDA) approved Smegalutide injection for the control of blood sugar in adults with type 2 diabetes.
In January 2020, it was approved by the FDA to reduce the risk of major cardiovascular adverse events in adults with type 2 diabetes with cardiovascular disease.
On December 4, 2020, Novo Nordisk submitted to the FDA a marketing application for weight loss with Smeiglutide 2.4mg subcutaneously injected once a week.
In April 2021, it was approved by the State Food and Drug Administration (NMPA) for the treatment of adult type 2 diabetes mellitus and reducing the risk of cardiovascular adverse events in patients with T2DM combined with cardiovascular disease.
On December 3, 2021, it was included in the "National Basic Medical Insurance, industrial injury Insurance and maternity Insurance Drug Catalog (2021)".
character
This product is colorless or almost colorless clear isotonic liquid; pH=7.4.
Fold edit this paragraph for indications
This product is suitable for glycemic control in adults with type 2 diabetes: adults with type 2 diabetes who are treated with metformin and/or sulfonylurea on the basis of diet control and exercise and still have poor glycemic control.
It is indicated to reduce the risk of major cardiovascular adverse events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus with cardiovascular disease.
Fold and edit this section specification
The specifications of this product are:
1.34mg/ml, 1.5ml (Pre-filled Injection pen)
1.34mg/ml, 3ml (Pre-filled Injection pen)
Before using Ozempic, make sure your doctor or pharmacist has instructed you on how to properly administer the medication.
Prior to injection, inspect the product for any discoloration or particles. Do not use it if either are present.
Clean the injection with alcohol and a swab before injection.
Rotate the site of injection to lower the risk of skin complications.
Inject the medication under the skin in the upper arm, thigh or abdomen as directed by your pharmacist, nurse or doctor.
Ozempic is injected once per week. Use a calendar or phone app to keep a consistent dosage schedule.
Your doctor may recommend starting off with a lower dose and gradually increasing over tie to reduce the chance of side effects. This medication can be used with or without meals.
Follow your doctors treatment plan which should include dietary changes and regular exercise. Inform your doctor if your condition does not get better or gets worse.
Zangu is a professional company focusing on the development of medical and beauty products. Our products is mainly of a series of dermal fillers that are used to treat signs of aging.The gel is clear, colorless and biodegradable.The products are developed to smooth outlines and wrinkles, shape facial contours and add volume to lips. It is very safe and effective to treat the entire face creating a more beautiful and youthful look.
1. who are we?
We are based in Henan, China, start from 2021,sell to North America(25.00%),Eastern Europe(15.00%),Mid East(15.00%),South America(10.00%),Eastern Asia(10.00%),Western Europe(10.00%),Central America(5.00%),Southeast Asia(3.00%),Africa(2.00%),Northern Europe(2.00%),Southern Europe(2.00%),Oceania(1.00%). There are total about 51-100 people in our office.
2. how can we guarantee quality?
Always a pre-production sample before mass production;
Always final Inspection before shipment;
3. what services can we provide?
Accepted Delivery Terms: FOB,CFR,CIF,EXW,FAS,CIP,FCA,CPT,DEQ,DDP,DDU,Express Delivery,DAF,DES;
Accepted Payment Currency:USD,EUR,JPY,CAD,AUD,HKD,GBP,CNY,CHF;
Accepted Payment Type: T/T,L/C,D/P D/A,MoneyGram,Credit Card,PayPal,Western Union,Cash,Escrow;
Language Spoken:English,Chinese,Spanish,Japanese,Portuguese,German,French,Russian,Korean,Hindi,Italian
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}